american

Geotab Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Excellence in Commercial Vehicle Fleet Management Leadership

Recognized for market leadership, innovation, and customer-centric fleet management and telematics solutions across North America.SAN ANTONIO, Jan. 15, 2026 /PRNewswire/…

2 months ago

NORTH AMERICAN AND EUROPEAN MANUFACTURERS’ PURCHASING DECLINES AGAIN IN DECEMBER, SIGNALING SLOWER CONDITIONS HEADING INTO 2026: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Ongoing weakness in North American and European factory purchasing points to a deteriorating near-term outlook for Western goods producersAsian manufacturers…

2 months ago

Hughes Network Systems Receives Frost & Sullivan’s 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity

The company is honored for delivering superior customer purchase and ownership experiences through advanced innovation, operational efficiency, and secure hybrid…

3 months ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…

3 months ago

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

December 11, 2025 18:22 ET  | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

3 months ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

4 months ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

4 months ago

American Society of Clinical Oncology (ASCO) announces dates for 2026 ASCO Breakthrough and begins accepting submissions for novel oncology research

Global oncology society calls for abstract submissions for research that is shaping the future of cancer care in advance of…

4 months ago

Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American Customer Value Leadership Recognition for Excellence in Patient-Centered Care Delivery

Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care modelsSAN ANTONIO, Dec. 2, 2025 /PRNewswire/…

4 months ago